3‐O‐acetylrubianol C (3AR‐C) induces RIPK1‐dependent programmed cell death by selective inhibition of IKKβ
Autor: | Hee Sun Byun, Gang Min Hur, Kyeong Ah Park, So-Ra Lee, Kyung-Cheol Sohn, Xuezhe Piao, Han-Ming Shen, Eunjin Ju, Khong Trong Quan, Kidong Kang, MinKyun Na |
---|---|
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
Programmed cell death Magnetic Resonance Spectroscopy Cell Survival Necroptosis Programmed Cell Death 1 Receptor Apoptosis Biochemistry Mice 03 medical and health sciences RIPK1 0302 clinical medicine Cell Line Tumor Genetics Animals Humans Kinase activity Molecular Biology Tumor Necrosis Factor-alpha Kinase Chemistry I-kappa B Kinase 030104 developmental biology Receptors Tumor Necrosis Factor Type I Cancer research Phosphorylation Tumor necrosis factor alpha 030217 neurology & neurosurgery Biotechnology |
Zdroj: | The FASEB Journal. 34:4369-4383 |
ISSN: | 1530-6860 0892-6638 |
Popis: | In tumor necrosis factor (TNF) signaling, phosphorylation and activation of receptor interacting protein kinase 1 (RIPK1) by upstream kinases is an essential checkpoint in the suppression of TNF-induced cell death. Thus, discovery of pharmacological agents targeting RIPK1 may provide new strategies for improving the therapeutic efficacy of TNF. In this study, we found that 3-O-acetylrubianol C (3AR-C), an arborinane triterpenoid isolated from Rubia philippinesis, promoted TNF-induced apoptotic and necroptotic cell death. To identify the molecular mechanism, we found that in mouse embryonic fibroblasts, 3AR-C drastically upregulated RIPK1 kinase activity by selectively inhibiting IKKβ. Notably, 3AR-C did not interfere with IKKα or affect the formation of the TNF receptor1 (TNFR1) complex-I. Moreover, in human cancer cells, 3AR-C was only sufficient to sensitize TNF-induced cell death when c-FLIPL expression was downregulated to facilitate the formation of TNFR1 complex-II and necrosome. Taken together, our study identified a novel arborinane triterpenoid 3AR-C as a potent activator of TNF-induced cell death via inhibition of IKKβ phosphorylation and promotion of the cytotoxic potential of RIPK1, thus providing a rationale for further development of 3AR-C as a selective IKKβ inhibitor to overcome TNF resistance in cancer therpay. |
Databáze: | OpenAIRE |
Externí odkaz: |